Welcome back to Tufts in Translation where we will spotlight faculty advancing new therapeutic approaches, targets, platforms, and delivery systems. Sessions will feature early-stage research across the drug discovery and design landscape, with an emphasis on translational potential and industry relevance. This session will be specifically centered around engineering spinal diversity for modeling and repair. 

Dr. Madeleine Oudin is a Tiampo Family Endowed Faculty Fellow and Associate Professor of Biomedical Engineering at Tufts University, after completing a PhD in Neuroscience from King’s College London and post-doctoral research at MIT. Her independent lab focuses on understanding the mechanisms by which the tumor microenvironment contributes to cancer metastasis and resistance to drugs.

She has received numerous awards for her research such as a K99/R00 Pathway to Independence Award in 2016 and a DP2 New Innovator Award in 2021 and was voted Exemplary Engineer by the graduate students in her department 3 years in a row for her commitment to promoting diversity, equity and inclusion in biomedical engineering. In 2021, the diagnosis of her daughter Margot with mutations in the SCN8A gene led to her to start research on SCN8A in her own lab, work to develop an ASO for patients with SCN8A, and become an advocate for individuals with epilepsy and other disabilities.